Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.48 AUD | +2.13% | +6.67% | +39.13% |
May. 17 | Capital One Initiates Immutep at Overweight Rating With $10 Price Target | MT |
May. 15 | Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
362M | - | |||||
50.93B | - | |||||
42.12B | ||||||
42.05B | ||||||
29.18B | ||||||
26.02B |
- Stock Market
- Equities
- IMM Stock
- Charts Immutep Limited
- Sector Chart